Chryseriol attenuates the progression of OVA-induced asthma in mice through NF-κB/HIF-1α and MAPK/STAT1 pathways

Main Article Content

Shangyao Mo
Hao Deng
Yong Xie
Lixia Yang
Lili Wen


asthma, chryseriol, NF-κB/HIF-1α and MAPK/STAT1 pathways, ovalbumin


Background: Asthma is a hackneyed chronic inflammatory disease of the airway. Chryseriol (CSR) is a kind of flavonoid, and has the effect of bronchiectasis, indicating its potential application for treating respiratory diseases. However, the functions of CSR in asthma have not been reported till now.

Materials and methods: The histopathologic changes of the lung tissues were assessed by hematoxylin and eosin staining. The cell apoptosis was identified through terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling assay. Total numbers of eosinophils, neutrophils, and macrophages were assessed under microscope. The levels of interleukin (IL)-1β, IL-4, IL-5, and IL-13 were detected by enzyme-linked-immunosorbent serologic assay. The airway hyper-responsiveness (AHR) was evaluated by the whole body plethysmography. The levels of methane dicarboxylic aldehyde, superoxide dismutase, glutathione S-transferase, and glutathione in lung homogenates were confirmed by using corresponding commercial kits. The protein expressions were examined by Western blot analysis.

Results: The ovalbumin (OVA) was utilized to establish asthma mouse model. At first, it was revealed that CSR treatment reduced lung injury in OVA-stimulated mice. Moreover, cell apoptosis was enhanced after OVA stimulation but was attenuated by CSR treatment. In addition, CSR treatment decreased the infiltration of inflammatory cells and the production of inflammatory factors in OVA-treated mice. Further investigations demonstrated that CSR treatment relieved AHR in OVA-stimulated mice. The oxidative stress was strengthened in OVA-treated mice, but these effects were relieved by CSR treatment. Lastly, it was discovered that CSR treatment retarded nuclear factor kappa B (NF-κB)/hypoxia-inducible factor 1 alpha (HIF-1α) and p38 mitogen-activated protein kinase (MAPK)/signal transducer and activator of transcription 1 (STAT1) pathways in OVA-triggered asthma mice.

Conclusion: Our findings proved that CSR attenuated the progression of OVA-induced asthma in mice through inhibiting NF-κB/HIF-1α and MAPK/STAT1 pathways. This work might highlight the functions of CSR in the treatment of asthma.

Abstract 114 | PDF Downloads 107 HTML Downloads 8 XML Downloads 7


1. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Asthma. Lancet. 2018:391(10122):783–800. 10.1016/S0140-6736(17)33311-1

2. Poddighe D, Brambilla I, Licari A, Marseglia GL. Omalizumab in the therapy of pediatric asthma. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):103–109. 10.2174/1872213X12666180430161351

3. Gordon BR. Asthma history and presentation. Otolaryngol Clin North Am, 2008:41(2):375–85, vii–viii. 10.1016/j.otc.2007.11.007

4. Munakata M. Airway remodeling and airway smooth muscle in asthma. Allergol Int. 2006:55(3):235–43. 10.2332/allergolint.55.235

5. Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in children. J Allergy Clin Immunol Pract. 2014:2(5):489–500. 10.1016/j.jaip.2014.06.022

6. Haktanir Abul M, Phipatanakul W. Severe asthma in children: Evaluation and management. Allergol Int. 2019;68(2):150–157. 10.1016/j.alit.2018.11.007

7. Creticos PS. Treatment options for initial maintenance therapy of persistent asthma: A review of inhaled corticosteroids and leukotriene receptor antagonists. Drugs. 2003;63(Suppl 2):1–20. 10.2165/00003495-200363002-00002

8. Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Coch Database Syst Rev. 2015;2015(11):Cd007949. 10.1002/14651858.CD007949.pub2

9. Lommatzsch M, Buhl R, Korn S. The treatment of mild and moderate asthma in adults. Dtsch Arztebl Int. 2020;117(25):434–444. 10.3238/arztebl.2020.0434

10. Trivedi M, Denton E. Asthma in children and adults-what are the differences and what can they tell us about asthma? Front Pediatr. 2019;7:256. 10.3389/fped.2019.00256

11. Tanaka T, Takahashi R. Flavonoids and asthma. Nutrients. 2013;5(6):2128–43. 10.3390/nu5062128

12. Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem. 2019;299:125124. 10.1016/j.foodchem.2019.125124

13. Aboulaghras S, Sahib N, Bakrim S, Benali T, Charfi S, Guaouguaou FE, et al. Health benefits and pharmacological aspects of chrysoeriol. Pharmaceuticals (Basel). 2022; 15(8):973. 10.3390/ph15080973

14. Mishra B, Priyadarsini KI, Kumar MS, Unnikrishnan MK, Mohan H. Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol. Bioorg Med Chem. 2003;11(13):2677–85. 10.1016/S0968-0896(03)00232-3

15. Han LK, et al. Anti-obesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana. Phytother Res. 2003;17(10):1195–8. 10.1002/ptr.140510.1002/ptr.1404

16. Skaltsa H, Bermejo P, Lazari D, Silvan AM, Skaltsounis AL, Sanz A, et al. Inhibition of prostaglandin E2 and leukotriene C4 in mouse peritoneal macrophages and thromboxane B2 production in human platelets by flavonoids from Stachys chrysantha and Stachys candida. Biol Pharm Bull. 2000;23(1):47–53. 10.1248/bpb.23.47

17. Yoon HS, Park CM. Chrysoeriol ameliorates COX-2 expression through NF-κB, AP-1 and MAPK regulation via the TLR4/MyD88 signaling pathway in LPS-stimulated murine macrophages. Exp Ther Med. 2021;22(1):718. 10.3892/etm.2021.10150

18. Wu JY, Chen YJ, Bai L, Liu YX, Fu XQ, Zhu PL, et al. Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways. Phytomedicine. 2020;68:153173. 10.1016/j.phymed.2020.153173

19. Choi DY, Lee JY, Kim MR, Woo ER, Kim YG, Kang KW. Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation. J Biomed Sci. 2005;12(6):949–59. 10.1007/s11373-005-9028-8

20. Khan AU, Gilani AH. Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol. Eur J Nutr. 2006;45(8):463–9. 10.1007/s00394-006-0620-0

21. Casaro M, Souza VR, Oliveira FA, Ferreira CM. OVA-induced allergic airway inflammation mouse model. Methods Mol Biol. 2019;1916:297–301. 10.1007/978-1-4939-8994-2_28

22. Dogan MF, Parlar A, Cam SA, Tosun EM, Uysal F, Arslan SO. Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma. Pulm Pharmacol Ther. 2020;63:101936. 10.1016/j.pupt.2020.101936

23. Limboonreung T, Tuchinda P, Chongthammakun S. Chrysoeriol mediates mitochondrial protection via PI3K/Akt pathway in MPP(+)-treated SH-SY5Y cells. Neurosci Lett. 2020;714:134545. 10.1016/j.neulet.2019.134545

24. Wu JY, Chen YJ, Fu XQ, Li JK, Chou JY, Yin CL, et al. Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling. BMC Compl Med Ther. 2022;22(1):73. 10.1186/s12906-022-03553-w

25. Min DY, Jung E, Ahn SS, Lee YH, Lim Y, Shin SY. Chrysoeriol prevents TNFα-induced CYP19 gene expression via EGR-1 downregulation in MCF7 breast cancer cells. Int J Mol Sci. 2020;21(20):7523. 10.3390/ijms21207523

26. Huang CY, Hu RC, Li J, Chen BB, Dai AG. α1-Antitrypsin alleviates inflammation and oxidative stress by suppressing autophagy in asthma. Cytokine. 2021;141:155454. 10.1016/j.cyto.2021.155454

27. Zhu L, Chen X, Chong L, Kong L, Wen S, Zhang H, et al. Adiponectin alleviates exacerbation of airway inflammation and oxidative stress in obesity-related asthma mice partly through AMPK signaling pathway. Int Immunopharmacol. 2019;67:396–407. 10.1016/j.intimp.2018.12.030

28. Wu SJ, Liou CJ, Chen YL, Cheng SC, Huang WC. Fucoxanthin ameliorates oxidative stress and airway inflammation in tracheal epithelial cells and asthmatic mice. Cells. 2021;10(6):1311. 10.3390/cells10061311

29. Raju KR, Kumar MN, Gupta S, Naga ST, Shankar JK, Murthy V, et al. 5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthma. Pulm Pharmacol Ther. 2014;29(2):209–16. 10.1016/j.pupt.2014.07.007

30. Wu S, Li H, Yu L, Wang N, Li X, Chen W. IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. Immunol Lett. 2017;192:20–6. 10.1016/j.imlet.2017.10.006

31. Bai D, Sun T, Lu F, Shen Y, Zhang Y, Zhang B, et al. Eupatilin suppresses OVA-induced asthma by inhibiting NF-κB and MAPK and activating Nrf2 signaling pathways in mice. Int J Mol Sci. 2022;23(3):1582. 10.3390/ijms23031582

32. Li C, Deng C, Zhou T, Hu J, Dai B, Yi F, et al. MicroRNA-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the FGF1/MAPK/STAT1 axis. Int J Biol Sci. 2021;17(7):1795–1807. 10.7150/ijbs.59715

33. Li C, Deng C, Zhou T, Hu J, Dai B, Yi F, et al. Importance of basophils in eosinophilic asthma: the murine counterpart. J Biol Regul Homeost Agents. 2018;32(2):335–9.

34. Poddighe D, Mathias CB, Freyschmidt EJ, Kombe D, Caplan B, Marseglia GL, et al. Basophils are rapidly mobilized following initial aeroallergen encounter in naïve mice and provide a priming source of IL-4 in adaptive immune responses. J Biol Regul Homeost Agents. 2014;28(1):91–103.